BRBS
Blue Ridge Bankshares, Inc.
There isn't enough reported data to score BRBS yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
BRBS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
BRBS's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like BRBS.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
BRBS PE Valuation
BRBS has no meaningful PE right now: it lost money over the past year.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
BRBS Forward outlook
There aren't enough analyst estimates for BRBS to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
BRBS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$0.92 | +$1.74 |
| Q2 2024 | -$3.11 | -$2.78 |
| Q1 2024 | -$3.09 | -1817% |
| Q4 2023 | -$2.73 | -397% |
| Q3 2023 | -$2.66 | -232% |
| Q2 2023 | -$0.33 | -115% |
| Q1 2023 | $0.18 | -95% |
MS has the stronger earnings trend. Trailing diluted EPS is down 100% for BRBS versus MS up 29%.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
BRBS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20M | -22% |
| Q2 2026 | $18.3M | -21% |
| Q1 2026 | $19.3M | -13% |
| Q4 2025 | $20.8M | -4.7% |
| Q3 2025 | $25.7M | +18% |
| Q2 2025 | $23.1M | +13% |
| Q1 2025 | $22.1M | -22% |
| Q4 2024 | $21.8M | -16% |
BRBS's revenue has slid since its 2021 peak: $20M last quarter, down 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -22% | -51 points |
| Q2 2026 | -8.9% | -17 points |
| Q1 2026 | 5.8% | +9.8 points |
| Q4 2025 | 26% | +38 points |
| Q3 2025 | 29% | +22 points |
| Q2 2025 | 7.7% | +67 points |
| Q1 2025 | -4% | +7.7 points |
| Q4 2024 | -12% | +17 points |
BRBS's operating margin was −22% last quarter, down 51 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over BRBS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over BRBS on profitability, with a higher operating margin.
BRBS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.5M | -21% |
| Q2 2026 | $1.5M | -86% |
| Q1 2026 | $14.6M | +$18.2M |
| Q4 2025 | -$699K | +$17.5M |
| Q3 2025 | $5.7M | -76% |
| Q2 2025 | $10.5M | +$15.5M |
| Q1 2025 | -$3.6M | +$4M |
| Q4 2024 | -$18.2M | -190% |
BRBS has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
BRBS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +127K shares |
| 1 year | -11% | -10.8M shares |
| 3 years | +370% | +69.8M shares |
| 5 years | +375% | +70M shares |
BRBS has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $6.7M |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
BRBS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 89.6x | High |
| Q2 2026 | 7.5x | High |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 6.2x | High |
| Q2 2025 | 37.9x | High |
| Q1 2023 | 7.9x | High |
| Q4 2022 | 11.4x | High |
BRBS's net debt is more than 20 years of its operating earnings (EBITDA), up from 6.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BRBS.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS has the edge over BRBS on leverage, with a lower net debt burden relative to earnings.
BRBS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.8 | Neutral |
| Stochastic | 67.1 | Neutral |
BRBS's weekly RSI is 58 (neutral) and its Stochastic is 67 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
BRBS PE vs Financial Services Sector
| Metric | BRBS | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 13x | 184% above |
| PE % | 92 | 63 | 29 pts above |
BRBS has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over BRBS on valuation relative to its sector.
BRBS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.95 | 2% above |
| 20 week MA | $3.81 | 5.8% above |
| 50 week MA | $3.88 | 3.9% above |
| 100 week MA | $3.77 | 6.9% above |
| 200 week MA | $4.53 | 11% below |
BRBS has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
BRBS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.7 | $11.9 | -13% |
| 2021 | $11.9 | $17.8 | +49% |
| 2022 | $17.8 | $12.4 | -30% |
| 2023 | $12.4 | $3.03 | -76% |
| 2024 | $3.03 | $3.19 | +5.3% |
| 2025 | $3.19 | $4.37 | +37% |
| 2026 YTD | $4.37 | $4.03 | -7.8% |
BRBS has finished lower in three of the last six years. It's down 7.8% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over BRBS on returns for 2026, with the stronger performance.